Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent.

@article{Bower2019GadoliniumBasedMC,
  title={Gadolinium-Based MRI Contrast Agents Induce Mitochondrial Toxicity and Cell Death in Human Neurons, and Toxicity Increases With Reduced Kinetic Stability of the Agent.},
  author={Danielle V. Bower and Johannes K Richter and Hendrik von Tengg-Kobligk and Johannes T. Heverhagen and Val Murray Runge},
  journal={Investigative Radiology},
  year={2019}
}
OBJECTIVES This preclinical study was devised to investigate potential cellular toxicity in human neurons induced by gadolinium-based contrast agents (GBCAs) used for contrast-enhanced magnetic resonance imaging (MRI). Neurons modeling a subset of those in the basal ganglia were tested, because the basal ganglia region is 1 of 2 brain regions that displays the greatest T1-dependent signal hyperintensity changes. METHODS Eight GBCAs were tested. Dopaminergic neurons modeling a subset of those… 

Is Gadolinium Staining of the Brain a Real Concern When Ordering Brain MRI?: Pro vs Con

applying imaging techniques to evaluate brain micro-structural and functional integrity, imaging and diffusion-weighted imaging in multiple sclerosis patients receiving cumulative doses of GBCA

Gadolinium retention in the ischemic cerebrum: Implications for pain, neuron loss, and neurological deficits

Neither gadobutrol nor gadopentetate worsened neuron loss, glia activation, brain atrophy, neurological deficits, or hippocampus-dependent memory after tMCAO, which may be an important consideration for patients with central post-stroke pain and those who are sensitive to pain and about to receive multiple GBCA administrations.

Employing Gadolinium Micro-Disks as Temperature Probes for Magnetic Resonance Imaging

Gadolinium Deposition Disease: A Case Report and the Prevalence of Enhanced MRI Procedures Within the Veterans Health Administration

Punitioners should be aware of long-term intracellular Gd retention (including the brain) as patients increasingly turn to consultants with concerns about Gd deposition disease.

Arterial spin labeling of nasopharyngeal carcinoma shows early therapy response

ASL permits a noninvasive approach to predicting the early efficacy of chemoradiotherapy for NPC, and has high diagnostic efficacies in predicting sensitivity to cheMoradiotherapy and residual tumors.

Different Impact of Gadopentetate and Gadobutrol on Inflammation-Promoted Retention and Toxicity of Gadolinium Within the Mouse Brain

Comparing the kinetics and retention profiles of Gd in inflamed and healthy brains after application of the macrocyclic Gd-based contrast agent (GBCA) gadobutrol or the linear GBCA gadopentetate found neuroinflammation promoted increased Gd retention in the brain for both GBCAs.

Augmented T1‐weighted steady state magnetic resonance imaging

An augmented T1‐weighted (aT1W) method to extract the signal ratio between routine GRE T1W and proton density‐ Weighted signals that effectively removes the non‐T1 effects from the original T1 W signals, including protondensity, T2* decay, and coil sensitivity is proposed.

Genotoxic effects of gadobutrol and gadoversetamide active substances used in magnetic resonance imaging in human peripheral lymphocytes in vitro

Both the contrast agents are likely to induce genotoxic risk in PBLs, however, different concentrations and treatment periods should be examined in vitro and specifically in vivo with different test systems for the safer usage of these contrast agents.

Altered Plasma Mitochondrial Metabolites in Persistently Symptomatic Individuals after a GBCA-Assisted MRI

To molecularly characterize and explore potential metabolic associations with GDD symptoms, detailed clinical phenotypes were systematically obtained for a small cohort of individuals with persistent symptoms attributed to a GBCA-enhanced MRI and consistent with provisional diagnostic criteria.

MRI of Hands with Early Rheumatoid Arthritis: Usefulness of Three-Point Dixon Sequences to Quantitatively Assess Disease Activity

Three-point Dixon MRI may be a valuable alternative to the currently recommended sequences as it yields effective fat signal suppression, high imaging quality and reproducible assessment of disease activity.

References

SHOWING 1-10 OF 47 REFERENCES

Extent of Signal Hyperintensity on Unenhanced T1-weighted Brain MR Images after More than 35 Administrations of Linear Gadolinium-based Contrast Agents.

Increased signal intensity on unenhanced T1-weighted images was seen in the posterior thalamus, substantia nigra, red nucleus, cerebellar peduncle, colliculi, dentate nucleus, and globus pallidus.

The Developmental History of the Gadolinium Chelates as Intravenous Contrast Media for Magnetic Resonance

The developmental history of the gadolinium chelates is described, focusing, in part, on the seminal work with each of the major agents in use today, as well as current research directions involving this field, which is that of the intravenous contrast media for magnetic resonance, in the past 5 years.

The Use of Dichlorofluorescein as a Probe for Monitoring the Effects ofCalcium on ROS Production in Mitochondria

Dichlorofluorescein preloaded in mitochondria could serve a suitable probe for monitoring the effects of Ca2+ transport on ROS production, and it was shown that the rate of ROS formation under steady-state conditions was linearly dependent on the rates of Ca 2+-cycling and Ca2-stimulated respiration.

Exposure of Macrophages to Low-Dose Gadolinium-Based Contrast Medium: Impact on Oxidative Stress and Cytokines Production

The data suggest that there is upregulated inflammation even in the presence of low levels of GBCAs, even similar to the physiological condition in murine macrophage.

No Signal Intensity Increase in the Dentate Nucleus on Unenhanced T1-weighted MR Images after more than 20 Serial Injections of Macrocyclic Gadolinium-Based Contrast Agents

In this retrospective, institutional review board-approved study, 33 patients who underwent at least 20 consecutive MRI examinations with the exclusive use of macrocyclic GBCAs (gadoterate meglumine and gadobutrol) were analyzed.

Multimodal Imaging Study of Gadolinium Presence in Rat Cerebellum

Transmission electron microscopy analysis of cerebellums of renally impaired rats repeatedly injected with gadobenate and gadodiamide revealed the presence of Gd, consistent with the involvement of the glymphatic distribution pathway for GBCAs.

One-year Retention of Gadolinium in the Brain: Comparison of Gadodiamide and Gadoterate Meglumine in a Rodent Model.

T1 hyperintensity of the deep cerebellar nuclei was observed only in gadodiamide-treated rats and remained stable from the 1st month after the last injection, while no T1 hyper intensity was observed with gadoterate, consistent with a rapid, time-dependent washout of the intact gadolinium chelate.

Impact of the Glymphatic System on the Kinetic and Distribution of Gadodiamide in the Rat Brain: Observations by Dynamic MRI and Effect of Circadian Rhythm on Tissue Gadolinium Concentrations

It is confirmed that the cerebrospinal fluid is one potential pathway of gadolinium-based contrast agent entry into the brain and involvement of the glymphatic system seemed to be indicated in terms of the influence of sleep and anesthesia.